SAN MATEO, Calif.--(BUSINESS WIRE)--Luminate Health, a leader in healthcare technology solutions for the clinical laboratory and diagnostics market, has seen unparalleled success with the adoption of ...
Hosted on MSN
Hims & Hers enters direct-to-consumer lab testing
Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...
LOS ANGELES--(BUSINESS WIRE)--Curative Inc., a leading health services company that recently launched a new health plan out of Texas, announces the spin-off of Sensible Diagnostics, whose aim is to ...
Kantesti, the healthcare technology platform developed by PIYA AI, has announced significant expansion across European ...
Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating ...
Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination therapies hold promise, their toxicity to healthy tissue remains a major hurdle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback